ウォーブルグ効果を標的としたナノ医療:がん治療のための高度な戦略

Xin Wang¹, Wenyuan Yang¹, Bingyan Shen²

¹School of Life Sciences, Henan University, Kaifeng, 475000 Henan Province, China.

Critical reviews in oncology/hematology

|September 5, 2025

まとめ

ナノ医学は癌細胞の代謝の特徴であるワーブルグ効果を標的として癌と闘う新しいアプローチを提供しますこの戦略は癌の代謝をプログラムし治療の成果を向上させます

科学分野:

腫瘍学
ナノテクノロジー
メタボリック・エンジニアリング

背景:

癌は世界の主要な死因で制御不能な細胞増殖と代謝の変化が原因です
ガン細胞の糖分分解の強化は重要な代謝適応です
従来のがん治療は薬物投与と代謝経路の標的化で課題に直面しています

研究の目的:

癌におけるワーブルグ効果を検証する
代謝の再プログラムのためのナノ医療の進歩を探求する
ガン代謝を標的としたナノ医療の治療の可能性を強調する

主な方法:

ウォーバーグ効果に関する現在の文献のレビュー
ガン治療におけるナノ医療の応用に関する分析
メタボリックターゲティングのためのナノキャリアベースの戦略の議論.

主要な成果:

ナノ医療は精密な薬物投与と制御された放出を可能にします
ナノキャリアは,がん細胞の変異した代謝経路を特定することができます.
ナノ医療による癌細胞の代謝の再プログラムが治療の有望さを示しています

結論:

ナノ医療と代謝再プログラムが癌に対する強力な戦略です
ナノテクノロジーの介入でウォーブルグ効果を標的としたのが癌治療の新たな道です
ナノ医療に基づく代謝介入に関するさらなる研究は,臨床翻訳のために正当化されています.

キーワード:

癌の管理併用療法低酸素症乳酸代謝の再プログラムナノ医療ウォーバーグ効果

さらに関連する動画

09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K

09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.2K

関連する概念動画

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

02:49

Cancer Therapies

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.9K

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

01:46

Electron Transport Chain: Complex I and II

15.0K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

15.0K

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...